Navigation Links
Aeras Welcomes David Blumberg to its Board of Directors

ROCKVILLE, Md., July 20, 2015 /PRNewswire-USNewswire/ -- David L. Blumberg, M.B.A., an expert in the life sciences industry, recently joined Aeras's Board of Directors. He has more than 20 years of business and consulting experience across the life sciences continuum, including large global, specialty, and generic pharmaceuticals, biotech, and medical devices and products.  

Photo -

"We are delighted that David is bringing his extensive expertise to the Aeras Board," said Board Chair Lota S. Zoth. "David's vast experience advising clients in the life sciences will be a highly valuable asset for the organization as we seek to fulfill our mission."

Mr. Blumberg recently retired from KPMG where he led their U.S. Pharmaceuticals and Life Sciences Advisory practice. Previously, David was the Executive Vice President of Professional Services and Customer Support of a public software company that specializes in contract and demand management for life sciences corporations. He spent several years at Accenture, where he served as lead partner for the Pharmaceutical and Medical Products Industries and led one of the corporation's largest account relationships.

Mr. Blumberg has an M.B.A. from The Wharton School and a B.S. degree in mechanical engineering from Ohio State University. He is a guest lecturer at The Wharton School, the Harvard Business School and at the New York Institute of Technology. Mr. Blumberg also serves on the Board of Advisors for the Vagelos Life Sciences and Management Program at The Wharton School and the University of Pennsylvania.

About Aeras

Aeras is a nonprofit, global biotech organization developing new tuberculosis vaccines for the world, in partnership with other biotech, pharmaceutical, and academic organizations. Aeras has a staff of more than 100 people from countries around the world, and has offices in the U.S., Africa, and Asia. Aeras is funded primarily by the Bill & Melinda Gates Foundation and European donor governments. Support also is received from the U.S. government as well as from partnerships and collaborations with universities and pharmaceutical companies.

About the Aeras Board of Directors

Aeras is grateful to the members of its Board of Directors for their leadership and international expertise across a broad spectrum of backgrounds:

Lota S. Zoth, Former Sr. VP and CFO of MedImmune, Inc.; Barry Bloom, Ph.D., Distinguished Service Professor at Harvard University; Jim Connolly, Former President and CEO of Aeras; Marja Esveld, M.Sc., Sr. Advisor, Research and Innovation, Ministry of Health, The Netherlands; Thomas G. Evans, M.D., Aeras CEO; Marian Eslie Jacobs, former Dean and Emeritus Professor of Paediatrics and Child Health Faculty of Sciences at the University of Cape Town; Michel Kazatchkine, United Nations Secretary-General's Special Envoy on HIV/AIDS in Eastern Europe and Central Asia; Wayne F. Pisano, President and CEO of VaxInnate; Regina Rabinovich, M.D., M.P.H., Exxon Mobil Malaria Scholar in Residence, Harvard School of Public Health; and Gerd Zettlmeissl, Ph.D., Former CEO of Intercell AG.

CONTACT: Ellen Wilcox,


Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Dara Erck Joins Aeras as V.P., External Affairs
2. Virginia Womens Center Welcomes The Newest Breakthrough In Womens Health Treatment
3. American Family Care Welcomes New Chief Marketing Officer
4. Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned
5. Prime Therapeutics welcomes FDAs approval of first biosimilar in U.S., but says more clarity is needed
6. NanoSmart Welcomes Reg Wilson, Founder of EPIC Wealth, to Advisory Board
7. Biorasi Boosts Executive Team; Welcomes Karen Bertoli as Vice President and Chief Marketing Officer
8. Renova Therapeutics welcomes new board member, raises $7.52 million in Series C financing round
9. Medimetriks Pharmaceuticals, Inc. Welcomes Independent Directors Andrew Lary and William Resnick to its Board of Directors
10. Stryker, The Official Joint Replacement Products Of The PGA TOUR, Welcomes Golf Fans To Its Home State Of New Jersey For The Barclays
11. Pinney Associates, Inc. Welcomes Dr. Bethea (Annie) Kleykamp, Science Writer and Expert in Pharmacology and Drug-Dependence
Post Your Comments:
(Date:10/11/2017)... CHICAGO , Oct. 11, 2017  Hill-Rom Holdings, ... its Aspen Surgical facility in Las Piedras, ... surgical scalpels and blades. ... confirmed that the facility sustained minor structural damage, temporary ... Hurricane Maria. Repairs have been completed, manufacturing operations have ...
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
Breaking Medicine News(10 mins):